Clinical trial
Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With…
NCT00399763 · Denver Health and Hospital Authority, Other · Completed
Key facts
| NCT number | NCT00399763 |
|---|---|
| Title | Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder |
| Official title | A Randomized, Placebo-controlled Trial of Atomoxetine for Attention Deficit Hyperactivity Disorder in Adolescents With Substance Use Disorder (SUD) |
| Lead sponsor | Denver Health and Hospital Authority, Other |
| Collaborators | American Academy of Child Adolescent Psychiatry. |
| Status | Completed |
| Study type | Interventional |
| Conditions | Attention Deficit Hyperactivity Disorder, Substance Abuse |
| Intervention type | Drug |
| Interventions | Atomoxetine, Placebo |
| Enrollment | 70 |
| Start date | Sep 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Nov 15, 2006 |
| Last update posted | Jul 8, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: